ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.691,32
0,05%
S&P 500
5.267,84
-0,74%
Dow Jones
39.065,26
-1,53%
Euro vs US Dollar
1,08155
-0,09%
Bitcoin
67.733,11
-1,98%
Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. iRadimed Corporation (IRMD)

  7. iRadimed Corporation (IRMD) News

IRMD

iRadimed (IRMD)

iRadimed Corporation
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:IRMD
DatumZeitQuelleÜberschriftSymbolFirma
09/05/202415h16Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:IRMDiRadimed Corporation
09/05/202406h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:IRMDiRadimed Corporation
06/05/202422h15Edgar (US Regulatory)Form S-3/A - Registration statement under Securities Act of 1933: [Amend]NASDAQ:IRMDiRadimed Corporation
02/05/202414h30GlobeNewswire Inc.IRADIMED CORPORATION Announces First Quarter of 2024 Financial Results and the Declaration of its Regular Quarterly Cash Dividend of $0.15 Per ShareNASDAQ:IRMDiRadimed Corporation
25/04/202422h05GlobeNewswire Inc.IRADIMED CORPORATION to Hold 2024 First Quarter Financial Results Conference Call on May 2ndNASDAQ:IRMDiRadimed Corporation
13/03/202421h30GlobeNewswire Inc.IRADIMED CORPORATION To Participate at the 36th Annual Roth ConferenceNASDAQ:IRMDiRadimed Corporation
01/03/202414h30Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:IRMDiRadimed Corporation
13/02/202422h25Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:IRMDiRadimed Corporation
12/02/202418h03Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:IRMDiRadimed Corporation
09/02/202421h54Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:IRMDiRadimed Corporation
08/02/202414h05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IRMDiRadimed Corporation
08/02/202414h05GlobeNewswire Inc.IRADIMED CORPORATION Announces Fourth Quarter of 2023 and Full Year of 2023 Financial ResultsNASDAQ:IRMDiRadimed Corporation
02/02/202415h44Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:IRMDiRadimed Corporation
01/02/202422h05GlobeNewswire Inc.IRADIMED CORPORATION to Hold 2023 Fourth Quarter Financial Results Conference Call on February 8th.NASDAQ:IRMDiRadimed Corporation
09/01/202414h30GlobeNewswire Inc.IRADIMED CORPORATION Reports Unaudited Fourth Quarter and 2023 RevenueNASDAQ:IRMDiRadimed Corporation
02/01/202422h30GlobeNewswire Inc.IRADIMED CORPORATION To Present at the 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:IRMDiRadimed Corporation
28/12/202300h30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IRMDiRadimed Corporation
22/12/202323h15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IRMDiRadimed Corporation
20/12/202322h05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IRMDiRadimed Corporation
13/12/202322h05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IRMDiRadimed Corporation
13/12/202322h03Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:IRMDiRadimed Corporation
12/12/202322h01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IRMDiRadimed Corporation
12/12/202316h00GlobeNewswire Inc.IRADIMED CORPORATION Announces Establishment of a Quarterly Dividend of $0.15 per share and a Special Cash Dividend of $0.48 per shareNASDAQ:IRMDiRadimed Corporation
12/12/202300h00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IRMDiRadimed Corporation
06/12/202322h05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IRMDiRadimed Corporation
01/12/202322h05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IRMDiRadimed Corporation
30/11/202315h00GlobeNewswire Inc.IRADIMED CORPORATION Named a 2024 Most Successful Small-Cap Company in America by ForbesNASDAQ:IRMDiRadimed Corporation
16/11/202322h05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IRMDiRadimed Corporation
09/11/202322h15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IRMDiRadimed Corporation
06/11/202322h05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IRMDiRadimed Corporation
 Showing the most relevant articles for your search:NASDAQ:IRMD

Kürzlich von Ihnen besucht

BIT
F17364
Vontobel Financial Produ...
DOWI
DWEURT
DJ Total Europe Select R...
BIT
P20D31
NLBNPIT20D31 20240621 1.08
BOV
CRPG5R
CRISTAL PNA
BIT
NSCIT4000484
Republic of Finland
NASDAQ
DAVEW
Dave
BIT
UV4LRY
UniCredit Bank
BIT
F28759
Vontobel Financial Produ...
BIT
UB8PF1
Unicredit Bank
BIT
UV8CN5
UniCredit Bank
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten